Pancreatic Adenosquamous Carcinoma trials recruiting in Texas

All Pancreatic Adenosquamous Carcinoma trials nationally

Cities in Texas

Recruiting trials in Texas

• APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
  NCT04858334 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Bryan, Dallas, Fort Worth, Richardson
• Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
  NCT07491445 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas, Houston
• Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma
  NCT04157127 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston